Randolph Company’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $26.8M | Buy |
309,011
+14,183
| +5% | +$1.36M | 2.56% | 23 |
|
|
2025
Q4 | $28.3M | Buy |
294,828
+865
| +0.3% | +$84K | 2.72% | 20 |
|
|
2025
Q3 | $28M | Buy |
293,963
+13
| +0% | +$1.2K | 2.72% | 18 |
|
|
2025
Q2 | $25.6M | Buy |
293,950
+2,989
| +1% | +$253K | 2.63% | 19 |
|
|
2025
Q1 | $26.1M | Sell |
290,961
-1,349
| -0.5% | -$121K | 3.06% | 17 |
|
|
2024
Q4 | $23.3M | Buy |
292,310
+154
| +0.1% | +$13.3K | 2.61% | 17 |
|
|
2024
Q3 | $26.3M | Sell |
292,156
-1,211
| -0.4% | -$102K | 3.06% | 17 |
|
|
2024
Q2 | $23.1M | Buy |
293,367
+254
| +0.1% | +$20.8K | 2.83% | 19 |
|
|
2024
Q1 | $25.5M | Sell |
293,113
-991
| -0.3% | -$84.6K | 3.14% | 15 |
|
|
2023
Q4 | $24.2M | Buy |
+294,104
| New | +$22.4M | 3.22% | 12 |
|
|
2022
Q4 | – | Sell |
-175,349
| Closed | -$14.2M | – | 47 |
|
|
2022
Q3 | $14.2M | Buy |
175,349
+233
| +0.1% | +$20.9K | 2.24% | 23 |
|
|
2022
Q2 | $15.7M | Buy |
175,116
+136
| +0.1% | +$13.8K | 2.38% | 22 |
|
|
2022
Q1 | $19.4M | Buy |
174,980
+387
| +0.2% | +$40.9K | 2.49% | 20 |
|
|
2021
Q4 | $18.1M | Buy |
174,593
+408
| +0.2% | +$47.2K | 2.18% | 22 |
|
|
2021
Q3 | $21.8M | Hold |
174,185
| – | – | 2.81% | 20 |
|
|
2021
Q2 | $21.6M | Buy |
174,185
+45
| +0% | +$5.65K | 2.81% | 19 |
|
|
2021
Q1 | $20.6M | Buy |
174,140
+165
| +0.1% | +$19.3K | 2.81% | 18 |
|
|
2020
Q4 | $20.4M | Hold |
173,975
| – | – | 3.02% | 16 |
|
|
2020
Q3 | $18.1M | Sell |
173,975
-19
| -0% | -$1.91K | 3.11% | 16 |
|
|
2020
Q2 | $16M | Buy |
173,994
+20
| +0% | +$1.92K | 2.86% | 21 |
|
|
2020
Q1 | $15.7M | Sell |
173,974
-140
| -0.1% | -$14.9K | 3.11% | 20 |
|
|
2019
Q4 | $19.8M | Sell |
174,114
-95
| -0.1% | -$10.4K | 3.05% | 16 |
|
|
2019
Q3 | $18.9M | Buy |
174,209
+66,789
| +62% | +$6.97M | 3.42% | 13 |
|
|
2019
Q2 | $10.5M | Buy |
107,420
+305
| +0.3% | +$27.8K | 1.8% | 27 |
|
|
2019
Q1 | $9.76M | Buy |
107,115
+1,065
| +1% | +$95.3K | 1.91% | 24 |
|
|
2018
Q4 | $9.65M | Hold |
106,050
| – | – | 2.67% | 17 |
|
|
2018
Q3 | $10.4M | Buy |
106,050
+1,410
| +1% | +$130K | 1.74% | 26 |
|
|
2018
Q2 | $8.96M | Buy |
104,640
+1,410
| +1% | +$118K | 1.65% | 27 |
|
|
2018
Q1 | $8.28M | Sell |
103,230
-470
| -0.5% | -$38.8K | 1.5% | 28 |
|
|
2017
Q4 | $8.37M | Buy |
103,700
+400
| +0.4% | +$32K | 1.42% | 31 |
|
|
2017
Q3 | $8.03M | Buy |
+103,300
| New | +$8.58M | 1.49% | 28 |
|
|
2016
Q1 | – | Sell |
-3,417
| Closed | -$263K | – | 37 |
|
|
2015
Q4 | $263K | Hold |
3,417
| – | – | 0.07% | 32 |
|
|
2015
Q3 | $229K | Sell |
3,417
-2
| -0.1% | -$147 | 0.05% | 40 |
|
|
2015
Q2 | $253K | Buy |
3,419
+169
| +5% | +$12.9K | 0.06% | 47 |
|
|
2015
Q1 | $253K | Buy |
+3,250
| New | +$246K | 0.05% | 46 |
|
Other funds holding MDT
VCM
VPM
Randolph Company's MDT Position: Q1 2026 in Review
Randolph Company increased its Medtronic (MDT) stake by 4.8% in Q1 2026, buying an estimated $1.36M and bringing the position to 309,011 shares worth $26.8M. The position accounts for 2.56% of the portfolio, ranked #23.
Randolph Company first reported a position in MDT in Q1 2015 and has held it in 35 quarters since. The position peaked at $28.3M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Randolph Company held 309,011 shares of Medtronic worth $26.8M as of Q1 2026.
- Randolph Company bought 14,183 Medtronic shares in Q1 2026, an estimated $1.36M.
- Medtronic made up 2.56% of Randolph Company's portfolio in Q1 2026, its #23 holding.
- Randolph Company first reported a position in Medtronic in Q1 2015 and has held it in 35 quarters since.
- Randolph Company's Medtronic position peaked at $28.3M in Q4 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Randolph Company's 13F filing for Q1 2026, filed 24 Apr 2026.